ArticleeLife2017
Identification of highly-protective combinations of
Open access · goldAbstract read
In one paragraph
Article in eLife, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.
0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
5.7field-weighted citation impact, top 4% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
55 citing papers in PubMed, 79 citations in OpenAlex.
- Malaria serology for surveillance, insights into immunity, and vaccine development.Infection and immunity · 2026Review
- A longitudinal study of children identifies antibody Fc-mediated functions and antigen targets of immunity to Plasmodium vivax malaria.Immunity · 2026Article
- Cytokine signatures associated with persistent antibody responses to multipleFrontiers in immunology · 2026Article
- The pattern of gene amplification of members of the Plasmodium vivax erythrocyte binding-like proteins family across the Amazon rainforest.Malaria journal · 2025Article
- Systems approach identifies monocyte imbalance in symptomatic and asymptomatic P. vivax malaria.Molecular systems biology · 2025Article
- B-cell epitope mapping and characterization of antibody responses to recombinant PvRipr in malaria-exposed individuals.Frontiers in immunology · 2025Article
- Characterization of T and B cell epitopes in PvCyRPA by studying the naturally acquired immune response in Brazilian Amazon communities.Scientific reports · 2024Article
- Natural genetic diversity of the DBL domain of a novel member of the Plasmodium vivax erythrocyte binding-like proteins (EBP2) in the Amazon rainforest.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2024Article
- Dynamics of IgM and IgG Antibody Response Profile against Linear B-Cell Epitopes from Exoerythrocytic (CelTOS and TRAP) and Erythrocytic (CyRPA) Phases ofAntibodies (Basel, Switzerland) · 2024Article
- Evaluation of naturally acquired immune responses against novel pre-erythrocytic Plasmodium vivax proteins in a low endemic malaria population located in the Peruvian Amazon Basin.Malaria journal · 2024Article
- Profiling the antibody response of humans protected by immunization with Plasmodium vivax radiation-attenuated sporozoites.Scientific reports · 2024Article
- Antibody selection strategies and their impact in predicting clinical malaria based on multi-sera data.BioData mining · 2024Article
- Biomaterials for Drug Delivery and Human Applications.Materials (Basel, Switzerland) · 2024Review
- Immunogenicity of PvCyRPA, PvCelTOS and Pvs25 chimeric recombinant protein ofFrontiers in immunology · 2024Article
- Preliminary characterization of Plasmodium vivax sporozoite antigens as pre-erythrocytic vaccine candidates.PLoS neglected tropical diseases · 2023Article
- Construction, Expression, and Evaluation of the Naturally Acquired Humoral Immune Response againstInternational journal of molecular sciences · 2023Article
- Vaccination withScience translational medicine · 2023Article
- Anti-merozoite antibodies induce natural killer cell effector function and are associated with immunity against malaria.Science translational medicine · 2023Article
- IgM antibody responses againstFrontiers in cellular and infection microbiology · 2023Article
- Identification of novelFrontiers in cellular and infection microbiology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
24 authors at 10 institutions in 8 countries.
Camila Tenorio FrançaDivision of Population Health and Immunity, Walter and Eliza Hall Institute, Parkville, Australia.ORCID http://orcid.org/0000-0001-5885-4410
Michael T WhiteDivision of Population Health and Immunity, Walter and Eliza Hall Institute, Parkville, Australia.
Wen-Qiang HeDepartment of Medical Biology, University of Melbourne, Parkville, Australia.
Jessica B HostetlerMalaria Programme, Wellcome Trust Sanger Institute, Hinxton, United Kingdom.
Jessica BrewsterDivision of Infection and Immunity, Walter and Eliza Hall Institute, Parkville, Australia.
Gabriel FratoCenter for Global Health and Diseases, Case Western Reserve University, Cleveland, United States.
Indu MalhotraCenter for Global Health and Diseases, Case Western Reserve University, Cleveland, United States.
Jakub GruszczykDivision of Infection and Immunity, Walter and Eliza Hall Institute, Parkville, Australia.ORCID http://orcid.org/0000-0003-4536-2964
Christele HuonMalaria Parasite Biology and Vaccines Unit, Institut Pasteur, Paris, France.
Enmoore LinMalaria Immuno-Epidemiology Unit, PNG Institute of Medical Research, Yagaum, Papua New Guinea.
Benson KiniboroMalaria Immuno-Epidemiology Unit, PNG Institute of Medical Research, Yagaum, Papua New Guinea.
Anjali YadavaMalaria Vaccine Branch, Walter Reed Army Institute of Research, Silver Spring, United States.ORCID https://orcid.org/0000-0002-6751-954X
Peter SibaMalaria Immuno-Epidemiology Unit, PNG Institute of Medical Research, Yagaum, Papua New Guinea.
Mary R GalinskiInternational Center for Malaria Research, Education, and Development, Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, United States.
Julie HealerDepartment of Medical Biology, University of Melbourne, Parkville, Australia.
Chetan ChitnisMalaria Parasite Biology and Vaccines Unit, Institut Pasteur, Paris, France.
Alan F CowmanDepartment of Medical Biology, University of Melbourne, Parkville, Australia.ORCID http://orcid.org/0000-0001-5145-9004
Eizo TakashimaMalaria Vaccine Branch, Walter Reed Army Institute of Research, Silver Spring, United States.
Takafumi TsuboiDivision of Malaria Research, Proteo-Science Center, Ehime University, Matsuyama, Japan.
Wai-Hong ThamDepartment of Medical Biology, University of Melbourne, Parkville, Australia.
Rick M FairhurstLaboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, United States.
Julian C RaynerMalaria Programme, Wellcome Trust Sanger Institute, Hinxton, United Kingdom.
Christopher L KingCenter for Global Health and Diseases, Case Western Reserve University, Cleveland, United States.
Ivo MuellerDivision of Population Health and Immunity, Walter and Eliza Hall Institute, Parkville, Australia.ORCID http://orcid.org/0000-0001-6554-6889
The University of Melbourne · AUCenter for Global Health · USInstitut Pasteur · FRPapua New Guinea Institute of Medical Research · PGWalter and Eliza Hall Institute of Medical Research · AUNational Institutes of Health · USWalter Reed Army Institute of Research · USEhime University · JPEmory University · USWellcome Sanger Institute · GB
Funding
Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0MTransmissionU19AI089686 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI ZIMMERMAN, PETER A. · 2010 to 2016
$9.9MMedical Research Council MR/J002283/1Medical Research Council MR/L012170/1NIAID NIH HHS U19 AI089686NIH HHS P51 OD011132Wellcome Trust 098051Wellcome Trust 208693/Z/17/Z
Abstract
The study of antigenic targets of naturally-acquired immunity is essential to identify and prioritize antigens for further functional characterization. We measured total IgG antibodies to 38
Indexed as
Antibodies, ProtozoanAntigens, ProtozoanChild, PreschoolHumansImmunoglobulin GInfantMalaria VaccinesMalaria, VivaxPapua New GuineaPlasmodium vivaxProtozoan ProteinsRecombinant ProteinsAntibodies, ProtozoanAntigens, ProtozoanImmunoglobulin GMalaria VaccinesProtozoan ProteinsRecombinant Proteinsclinical malariaepidemiologyglobal healthIgG antibodynatural immunityPlasmodium vivaxprotectionvaccine
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.